NasdaqCM - Nasdaq Real Time Price USD
Ernexa Therapeutics Inc. (ERNA)
0.2080
+0.0100
+(5.05%)
At close: May 6 at 4:00:01 PM EDT
0.2001
-0.01
(-3.80%)
After hours: May 6 at 5:42:12 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHERINGTON CHARLES Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 2, 2025 | 20,401,600 |
| GURROLA SANDRA M Officer | Conversion of Exercise of derivative security | Jun 21, 2024 | 1,185 |
Related Tickers
KAPA Kairos Pharma, Ltd.
0.8565
+0.19%
ONCO Onconetix, Inc.
0.0694
-1.14%
HCWB HCW Biologics Inc.
6.68
-1.04%
ABP Abpro Corporation
0.2177
-4.93%
SLRX Salarius Pharmaceuticals, Inc.
0.7318
+4.08%
LYRA Lyra Therapeutics, Inc.
0.1020
-1.73%
CYCN Cyclerion Therapeutics, Inc.
3.0100
-0.99%
ENTO Entero Therapeutics, Inc.
0.3554
+0.57%
INTS Intensity Therapeutics, Inc.
0.5599
-1.94%
ALXO ALX Oncology Holdings Inc.
0.5037
-8.42%